
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others. Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0085 | -1.57407407407 | 0.54 | 0.579999 | 0.5042 | 35267 | 0.53829947 | CS |
4 | -0.0545 | -9.30034129693 | 0.586 | 0.75 | 0.5042 | 109934 | 0.59517451 | CS |
12 | -0.0085 | -1.57407407407 | 0.54 | 1.43 | 0.478 | 498157 | 0.66555376 | CS |
26 | -3.0185 | -85.0281690141 | 3.55 | 4.25 | 0.478 | 335200 | 0.74863467 | CS |
52 | -13.9685 | -96.3344827586 | 14.5 | 21.5 | 0.478 | 819604 | 7.99866631 | CS |
156 | -28.6935 | -98.1813515825 | 29.225 | 50 | 0.478 | 1362019 | 21.13840564 | CS |
260 | -32.9685 | -98.4134328358 | 33.5 | 111 | 0.478 | 1726321 | 38.11833487 | CS |
Symbol | Price | Vol. |
---|---|---|
AAPXT Rex 2X Long Apple Daily Target ETF | $ 0.00 (0.00%) | 0 |
AAPWRoundhill AAPL WeeklyPay ETF | $ 0.00 (0.00%) | 0 |
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | $ 0.00 (0.00%) | 0 |
AAAUGoldman Sachs Physical Gold ETF Shares | $ 0.00 (0.00%) | 0 |
AAAAlternative Access First Priority CLO Bond ETF | $ 0.00 (0.00%) | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions